Publications

Efficacy and Safety of Ct-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase Iii Study

AuthID
P-00V-MMA

Author(s)

Kwak, LW

Sancho, JM

Cho, SG

Nakazawa, H

Suzumiya, J

Tumyan, G

Kim, JS

Menne, T

[+3]·

Ruiz, EY

Popplewell, L

Ogura, M

Kim, WS

Lee, SJ

Kim, SH

Ahn, KY

Buske, C

View all authors

Document Type

Article

Year published

2022

Published

in CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, ISSN: 2152-2650

Volume: 22, Issue: 2, Pages: 89-97 (9)

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.clml.2021.08.005

Pubmed: 34686445

SCOPUS: 2-s2.0-85118188377

Wos: WOS:000757000400013

Source Identifiers

ISSN: 2152-2650

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Name	Name Order	Name	Name Order	Name
1	Kwak, LW;	2	Sancho, JM;	3	Cho, SG;
4	Nakazawa, H;	5	Suzumiya, J;	6	Tumyan, G;
7	Kim, JS;	8	Menne, T;	9	Mariz, J;
10	Ilyin, N;	11	Jurczak, W;	12	Martinez, AL;
13	Samoilova, O;	14	Zhavrid, E;	15	Ruiz, EY;
16	Trneny, M;	17	Popplewell, L;	18	Ogura, M;
19	Kim, WS;	20	Lee, SJ;	21	Kim, SH;
22	Ahn, KY;	23	Buske, C;

Efficacy and Safety of Ct-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase Iii Study

Useful Links

Get Help

Federated Authentication (Click on the image)

Efficacy and Safety of Ct-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase Iii Study

Useful Links

Get Help